Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1959 1
1960 1
1962 1
1963 1
1964 1
1967 10
1968 2
1972 1
1978 1
1979 2
1981 1
1982 1
1983 4
1984 2
1985 2
1986 5
1987 8
1988 6
1989 7
1990 4
1991 6
1992 6
1993 4
1994 3
1995 5
1996 8
1997 6
1998 10
1999 6
2000 8
2001 12
2002 14
2003 12
2004 14
2005 20
2006 18
2007 24
2008 26
2009 26
2010 34
2011 39
2012 39
2013 44
2014 52
2015 62
2016 71
2017 60
2018 83
2019 84
2020 122
2021 116
2022 117
2023 139
2024 143
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,358 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.
Johnson ML, Cho BC, Luft A, Alatorre-Alexander J, Geater SL, Laktionov K, Kim SW, Ursol G, Hussein M, Lim FL, Yang CT, Araujo LH, Saito H, Reinmuth N, Shi X, Poole L, Peters S, Garon EB, Mok T; POSEIDON investigators. Johnson ML, et al. Among authors: araujo lh. J Clin Oncol. 2023 Feb 20;41(6):1213-1227. doi: 10.1200/JCO.22.00975. Epub 2022 Nov 3. J Clin Oncol. 2023. PMID: 36327426 Free PMC article. Clinical Trial.
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes.
Bertoluci MC, Silva Júnior WS, Valente F, Araujo LR, Lyra R, de Castro JJ, Raposo JF, Miranda PAC, Boguszewski CL, Hohl A, Duarte R, Salles JEN, Silva-Nunes J, Dores J, Melo M, de Sá JR, Neves JS, Moreira RO, Malachias MVB, Lamounier RN, Malerbi DA, Calliari LE, Cardoso LM, Carvalho MR, Ferreira HJ, Nortadas R, Trujilho FR, Leitão CB, Simões JAR, Dos Reis MIN, Melo P, Marcelino M, Carvalho D. Bertoluci MC, et al. Among authors: araujo lr. Diabetol Metab Syndr. 2023 Jul 19;15(1):160. doi: 10.1186/s13098-023-01121-x. Diabetol Metab Syndr. 2023. PMID: 37468901 Free PMC article. Review.
Letter.
Kassar LML, Senna JP, Wayla K, Araujo LKR, Pereira BJ, Abensur H, Elias RM. Kassar LML, et al. Among authors: araujo lkr. Int J Artif Organs. 2024 Mar;47(3):127-128. doi: 10.1177/03913988241228677. Epub 2024 Feb 5. Int J Artif Organs. 2024. PMID: 38317083 No abstract available.
Macrolides allergy.
Araújo L, Demoly P. Araújo L, et al. Curr Pharm Des. 2008;14(27):2840-62. doi: 10.2174/138161208786369812. Curr Pharm Des. 2008. PMID: 18991703 Review.
Editorial: Progression of diabetic kidney disease.
de Ponte MC, de Araújo L. de Ponte MC, et al. Among authors: de araujo l. Front Nephrol. 2024 Jul 26;4:1439950. doi: 10.3389/fneph.2024.1439950. eCollection 2024. Front Nephrol. 2024. PMID: 39131170 Free PMC article. No abstract available.
Descending stair walking as exercise medicine.
Araújo LHL, Chen TC, Nosaka K, Lima LCR. Araújo LHL, et al. Br J Sports Med. 2024 Dec 5:bjsports-2024-108626. doi: 10.1136/bjsports-2024-108626. Online ahead of print. Br J Sports Med. 2024. PMID: 39638436 No abstract available.
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
Garon EB, Cho BC, Luft A, Alatorre-Alexander J, Geater SL, Kim SW, Ursol G, Hussein M, Lim FL, Yang CT, Araujo LH, Saito H, Reinmuth N, Medic N, Mann H, Shi X, Peters S, Mok T, Johnson M. Garon EB, et al. Among authors: araujo lh. Lung Cancer. 2023 Dec;186:107422. doi: 10.1016/j.lungcan.2023.107422. Epub 2023 Nov 11. Lung Cancer. 2023. PMID: 37992595 Free article. Clinical Trial.
A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study.
Garon EB, Cho BC, Luft A, Alatorre-Alexander J, Geater SL, Trukhin D, Kim SW, Ursol G, Hussein M, Lim FL, Yang CT, Araujo LH, Saito H, Reinmuth N, Kohlmann M, Lowery C, Mann H, Peters S, Mok TS, Johnson ML. Garon EB, et al. Among authors: araujo lh. Clin Lung Cancer. 2024 May;25(3):266-273.e5. doi: 10.1016/j.cllc.2024.03.003. Epub 2024 Mar 15. Clin Lung Cancer. 2024. PMID: 38584069 Free article. Clinical Trial. No abstract available.
Antifungal Resistance in Cryptococcal Infections.
Melhem MSC, Leite Júnior DP, Takahashi JPF, Macioni MB, Oliveira L, de Araújo LS, Fava WS, Bonfietti LX, Paniago AMM, Venturini J, Espinel-Ingroff A. Melhem MSC, et al. Among authors: de araujo ls. Pathogens. 2024 Jan 29;13(2):128. doi: 10.3390/pathogens13020128. Pathogens. 2024. PMID: 38392866 Free PMC article. Review.
Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study.
Barilar I, Fernando T, Utpatel C, Abujate C, Madeira CM, José B, Mutaquiha C, Kranzer K, Niemann T, Ismael N, de Araujo L, Wirth T, Niemann S, Viegas S. Barilar I, et al. Among authors: de araujo l. Lancet Infect Dis. 2024 Mar;24(3):297-307. doi: 10.1016/S1473-3099(23)00498-X. Epub 2023 Nov 10. Lancet Infect Dis. 2024. PMID: 37956677
1,358 results